Overview of Dr. Westbrook
Dr. Thomas Westbrook is an oncologist in Chicago, IL and is affiliated with Rush University Medical Center. He received his medical degree from University of Cincinnati College of Medicine and has been in practice 0 years. He is one of 57 doctors at Rush University Medical Center who specialize in Oncology. He has 5 publications and over 50 citings.
Office
1520 W Harrison St
Chicago, IL 60607Fax+1 312-563-0715
Education & Training
University of MichiganFellowship, Hematology and Medical Oncology, 2020 - 2023
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2017 - 2020
University of Cincinnati College of MedicineClass of 2017
Certifications & Licensure
IL State Medical License 2023 - 2026
MI State Medical License 2020 - 2026
MO State Medical License 2017 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 17 citationsTranscriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity.Thomas C Westbrook, Xiangnan Guan, Eva Rodansky, Diana Flores, Chia Jen Liu
Nature Communications. 2022-09-15 - 14 citationsThe Role of Epigenetic Change in Therapy-Induced Neuroendocrine Prostate Cancer Lineage Plasticity.William K Storck, Allison M May, Thomas C Westbrook, Zhi Duan, Colm Morrissey
Frontiers in Endocrinology. 2022-01-01 - 33 citationsRecent Advances in Epigenetic Biomarkers and Epigenetic Targeting in Prostate CancerAnbarasu Kumaraswamy, Katherine R. Welker Leng, Thomas C. Westbrook, Joel A. Yates, Shuang G. Zhao
European Urology. 2021-03-27
Journal Articles
- Comparative structural profiling of trichome specialized metabolites in tomato ( Solanumlycopersicum) and S. habrochaites: acylsugar profiles revealed by UHPLC/MS and NMRBanibrata Ghosh, Thomas C Westbrook, A Daniel Jones, Metabolomics, 9/2013
Press Mentions
Researchers Suggest How Cancer Treatment Rewires Engine of Prostate TumorsSeptember 15th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
